Engene Holdings Warrants Stock Fundamentals
| ENGNW Stock | 0.94 0.02 2.17% |
enGene Holdings Warrants fundamentals help investors to digest information that contributes to EnGene Holdings' financial success or failures. It also enables traders to predict the movement of EnGene Stock. The fundamental analysis module provides a way to measure EnGene Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EnGene Holdings stock.
At this time, EnGene Holdings' Income Before Tax is fairly stable compared to the past year. Net Income is likely to climb to about 66.6 M in 2025, whereas Other Operating Expenses is likely to drop slightly above 20.7 M in 2025. EnGene | Select Account or Indicator |
enGene Holdings Warrants Company EBITDA Analysis
EnGene Holdings' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current EnGene Holdings EBITDA | 62.3 M |
Most of EnGene Holdings' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, enGene Holdings Warrants is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
EnGene Ebitda
Ebitda |
|
According to the company disclosure, enGene Holdings Warrants reported earnings before interest,tax, depreciation and amortization of 62.3 M. This is 92.9% lower than that of the Biotechnology sector and 37.8% lower than that of the Health Care industry. The ebitda for all United States stocks is 98.4% higher than that of the company.
enGene Holdings Warrants Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining EnGene Holdings's current stock value. Our valuation model uses many indicators to compare EnGene Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EnGene Holdings competition to find correlations between indicators driving EnGene Holdings's intrinsic value. More Info.enGene Holdings Warrants is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . At this time, EnGene Holdings' Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value EnGene Holdings by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.EnGene EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EnGene Holdings' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EnGene Holdings could also be used in its relative valuation, which is a method of valuing EnGene Holdings by comparing valuation metrics of similar companies.EnGene Holdings is currently under evaluation in ebitda category among its peers.
EnGene Fundamentals
| Return On Equity | -1.23 | ||||
| Return On Asset | -0.22 | ||||
| Number Of Shares Shorted | 2.99 K | ||||
| EBITDA | 62.3 M | ||||
| Net Income | (55.14 M) | ||||
| Total Debt | 1.85 M | ||||
| Book Value Per Share | 5.21 X | ||||
| Cash Flow From Operations | (48.28 M) | ||||
| Number Of Employees | 31 | ||||
| Beta | -0.76 | ||||
| Total Asset | 311.17 M | ||||
| Retained Earnings | (254.73 M) | ||||
| Working Capital | 232.7 M | ||||
| Net Asset | 311.17 M |
About EnGene Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze enGene Holdings Warrants's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EnGene Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of enGene Holdings Warrants based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 3.8 M | 2.4 M | |
| Cost Of Revenue | 157.5 K | 140 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for EnGene Stock Analysis
When running EnGene Holdings' price analysis, check to measure EnGene Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EnGene Holdings is operating at the current time. Most of EnGene Holdings' value examination focuses on studying past and present price action to predict the probability of EnGene Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EnGene Holdings' price. Additionally, you may evaluate how the addition of EnGene Holdings to your portfolios can decrease your overall portfolio volatility.